FDA Inspection
Resilience US, Inc.Resilience US, Inc. – FDA Inspection, Nov 13, 2009
Record Details
This FDA Inspection record concerns Resilience US, Inc., with an inspection on November 13, 2009, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Resilience US, Inc.
- Inspection Date
- November 13, 2009
- Product Type
- Drugs
View Company Profile
ID · a6cce063-c616-4d41-a6a9-0b9d51829204
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 625796
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Resilience US, Inc.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| August 21, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 14, 2017 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| August 11, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 25, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 28, 2009 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Resilience US, Inc.
- FDA Inspection 1102300 - 2019-08-21
- FDA Inspection 1028333 - 2017-09-14
- FDA Inspection 1021959 - 2017-08-11
- FDA Inspection 897817 - 2014-09-25
- FDA Inspection 595314 - 2009-05-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.